Joshua H. Bilenker, President & CEO at Loxo Oncology, Inc. (LOXO), sold 6,900 shares at $165.95 ($1.2M) on 2018-10-03, disclosed to the SEC on 2018-10-05.
Open-market sale of $1.2M LOXO by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $165.95 | 1,225 | $203K | 17.5% |
| 2 | $167.09 | 673 | $112K | 9.7% |
| 3 | $168.29 | 1,297 | $218K | 18.8% |
| 4 | $169.00 | 3,705 | $626K | 54.0% |
| Total | $168.14 avg | 6,900 | $1.2M | 100% |
| Filing → |
| LOXO | SELL | 2018-12-12 | $2.7M | — | Filing → |
| LOXO | SELL | 2018-12-12 | $1.0M | — | Filing → |
| LOXO | SELL | 2018-11-28 | $1.2M | — | Filing → |